Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2017 | 1 |
2018 | 1 |
2019 | 2 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Systematic review and analysis of efficacy of recombinant factor IX products for prophylactic treatment of hemophilia B in comparison with rIX-FP.
J Med Econ. 2019 Oct;22(10):1014-1021. doi: 10.1080/13696998.2019.1620246. Epub 2019 Jun 5.
J Med Econ. 2019.
PMID: 31094591
Free article.
A systematic review and indirect statistical comparison was performed to evaluate the efficacy of both EHL and standard-acting rFIX products compared with rIX-FP in Phase III trials for prophylaxis in adult hemophilia B patients. Materials and methods: A systematic …
A systematic review and indirect statistical comparison was performed to evaluate the efficacy of both EHL and standard-acting rFIX products …
Outcome measures in haemophilia: a systematic review.
Boehlen F, Graf L, Berntorp E.
Boehlen F, et al.
Eur J Haematol Suppl. 2014 Aug;76:2-15. doi: 10.1111/ejh.12369.
Eur J Haematol Suppl. 2014.
PMID: 24957102
Review.
Outcome measurements in persons with haemophilia (PWH) have been limited to laboratory evaluation (factor VIII or IX levels) and clinical outcomes (such as bleeding frequency), morbidity (for example linked with arthropathy) and mortality. ...
Outcome measurements in persons with haemophilia (PWH) have been limited to laboratory evaluation (factor VIII or IX levels) and clin …
Item in Clipboard
Coronary angiography with or without percutaneous coronary intervention in patients with hemophilia-Systematic review.
Boehnel C, Rickli H, Graf L, Maeder MT.
Boehnel C, et al.
Catheter Cardiovasc Interv. 2018 Jul;92(1):1-15. doi: 10.1002/ccd.27255. Epub 2017 Sep 12.
Catheter Cardiovasc Interv. 2018.
PMID: 28895303
BACKGROUND: Hemophilia patients undergoing coronary angiography and PCI are at risk of bleeding due to deficiency of the essential clotting factors VIII or IX combined with the need of peri-interventional anticoagulation and antiaggregation and dual antiplatelet therapy (DAPT) af …
BACKGROUND: Hemophilia patients undergoing coronary angiography and PCI are at risk of bleeding due to deficiency of the essential clotting …
Item in Clipboard
Perioperative laboratory monitoring in congenital haemophilia patients with inhibitors: a systematic literature review.
Hart DP, Hay CRM, Liesner R, Tobaruela G, Du-Mont B, Makris M.
Hart DP, et al.
Blood Coagul Fibrinolysis. 2019 Oct;30(7):309-323. doi: 10.1097/MBC.0000000000000840.
Blood Coagul Fibrinolysis. 2019.
PMID: 31397688
Free article.
The identified studies were screened again to find articles reporting perioperative laboratory monitoring in patients with congenital haemophilia A or B, resulting in 24 articles undergoing data extraction. ...
The identified studies were screened again to find articles reporting perioperative laboratory monitoring in patients with congenital …
Item in Clipboard
Cite
Cite